Peptide

Teduglutide (Gattex)

FDA-approved product existsImmune & gut
Not yet scored

BioHarmony verdict

Awaiting review

No BioHarmony report yet. It is queued for review; until then, rely on the status and sources below.

What is Teduglutide (Gattex)?

FDA-approved teduglutide is marketed as Gattex for adults and pediatric patients one year and older with short bowel syndrome who are dependent on parenteral support.

Dosing as published

Approved labelGATTEX prescribing information for short bowel syndrome with dependence on parenteral support
PopulationAdults and pediatric patients one year and older covered by the approved GATTEX indication
Dose0.05 mg/kg once daily; the label specifies adjustments for pediatric patients weighing less than 10 kg and for moderate or severe renal impairment
RouteSubcutaneous injection, rotating among the four quadrants of the abdomen, thighs, and arms
FrequencyOnce daily
DurationLong-term use within the approved indication
PreparationReconstitute the 5 mg lyophilized single-dose vial using the supplied 0.5 mL Sterile Water for Injection. Gently roll the vial; do not shake. Use the reconstituted solution within 3 hours and discard unused portion.
Source: Dosage and Administration sections 2.1-2.3; Dosage Forms and Strengths section 3

More reported protocols

Members

Members can compare additional reported doses, schedules, and preparation notes.

Trust & sourcing

US approvalFDA-approved product exists
CompoundingFDA-approved product exists; compounded copies are not FDA approved
Last checked2026-07-13
Next review2026-10-11

Primary sources

  1. 7.5/10BPC-157Strong recommendRecoveryNot FDA approvedBPC-157 is a 15-amino-acid gastric peptide fragment with consistent preclinical repair data, including a 2025 sports-medicine systematic review of 36 studies with 35…
  2. 7.5/10TB-500 (Thymosin Beta-4 Fragment)Strong recommendRecoveryNot FDA approvedTB-500 is a synthetic LKKTETQ fragment marketed for soft-tissue repair, but most human evidence is on full-length topical thymosin beta-4: Sosne 2023 reported corneal…
  3. 7.4/10GHK-Cu (Copper Peptide)Strong recommendRecoveryNot FDA approvedGHK-Cu is a human copper-binding tripeptide with the best evidence for topical skin repair and wound healing, including Mulder 1994 diabetic ulcer data showing 98.5%…
  4. 7.3/10Thymosin Alpha-1Strong recommendRecoveryNot FDA approvedFDA identifies immunogenicity and peptide-impurity concerns for compounded thymosin alpha-1 and says available safety information is inadequate.

Free guide

The Ultimate Peptides Guide

Spot stronger candidates, weak evidence, and seller red flags before you buy.

Free. Includes evidence and regulatory updates. Unsubscribe anytime.